SGHT Stock Analysis: Buy, Sell, or Hold?
SGHT - Sight Sciences, Inc. Common Stock
$6.28
0.13 (2.11%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 04, 2026
Get Alerted When SGHT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called SGHT this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SGHT shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SGHT shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SGHT is currently trading at $6.28, which is considered slightly low relative to its 30-day fair value range of $6.25 to $8.11.
Technical Outlook: Technically, SGHT is in a strong uptrend. Immediate support is located at $5.94, while resistance sits at $6.72.
Market Sentiment: SGHT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (3th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $9.35 (+52.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SGHT is in a strong uptrend. Immediate support is located at $5.94, while resistance sits at $6.72.
Market Sentiment: SGHT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (3th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $9.35 (+52.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$6.25 -
$8.11
Company Quality Score
51/100
(HOLD)
Options IV Signal
3th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 3th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 52.0% below Wall St target ($9.35)
Fair Price Analysis
30-Day Fair Range
$6.25 -
$8.11
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$0.59
(9.4%)
Support & Resistance Levels
Support Level
$5.94
Resistance Level
$6.72
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-10.28
Wall Street Target
$9.35
(+52.0%)
Revenue Growth (YoY)
-1.2%
Profit Margin
-60.6%
Last updated: January 30, 2026 11:32 PM ET
Data refreshes hourly during market hours. Next update: 12:32 AM
Data refreshes hourly during market hours. Next update: 12:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGHT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Brenton Taylor
SELL
591 shares
2025-10-06
David Badawi
SELL
6033 shares
2025-10-03
Jeremy B Hayden
SELL
9731 shares
2025-10-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced SGHT Option Strategies
Professional options setups generated by AI based on today's SGHT price and gamma walls.
